Nevro Corp
(NVRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 114,374 | 100,162 | 93,571 | 82,148 | 107,944 |
| Cost of Goods | 33,116 | 30,222 | 29,628 | 28,939 | 31,790 |
| Gross Profit | 81,258 | 69,940 | 63,943 | 53,209 | 76,154 |
| Operating Expenses | 93,055 | 86,146 | 91,131 | 96,402 | 85,547 |
| Operating Income | -11,681 | -15,984 | -26,560 | -42,254 | -8,603 |
| Interest Expense | 2,778 | 2,755 | 2,710 | 2,688 | 2,642 |
| Other Income | 1,198 | 1,312 | 1,607 | 1,206 | 1,129 |
| Pre-tax Income | -13,261 | -17,427 | -27,663 | -43,736 | -10,116 |
| Income Tax | 481 | 420 | 358 | 340 | -509 |
| Net Income Continuous | -13,742 | -17,847 | -28,021 | -44,076 | -9,607 |
| Net Income | $-13,742 | $-17,847 | $-28,021 | $-44,076 | $-9,607 |
| EPS Basic Total Ops | -0.43 | -0.58 | -0.91 | -1.45 | -0.33 |
| EPS Basic Continuous Ops | -0.42 | -0.58 | -0.91 | -1.45 | -0.32 |
| EPS Diluted Total Ops | -0.43 | -0.58 | -0.91 | -1.45 | -0.33 |
| EPS Diluted Continuous Ops | -0.42 | -0.58 | -0.91 | -1.45 | -0.32 |
| EBITDA(a) | $-1,941 | $-14,502 | $-25,224 | $-41,137 | $-8,255 |